A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 532,730 shares of AMRX stock, worth $3.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
532,730
Previous 207,800 156.37%
Holding current value
$3.38 Million
Previous $1.26 Million 155.99%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$5.24 - $6.34 $1.7 Million - $2.06 Million
324,930 Added 156.37%
532,730 $3.23 Million
Q4 2023

Feb 13, 2024

BUY
$3.36 - $6.21 $314,832 - $581,877
93,700 Added 82.12%
207,800 $1.26 Million
Q3 2023

Nov 14, 2023

BUY
$2.76 - $4.59 $314,916 - $523,719
114,100 New
114,100 $482,000
Q4 2022

Feb 13, 2023

SELL
$1.96 - $2.61 $128,380 - $170,955
-65,500 Reduced 46.16%
76,400 $152,000
Q3 2022

Nov 14, 2022

SELL
$2.02 - $3.62 $61,610 - $110,410
-30,500 Reduced 17.69%
141,900 $287,000
Q2 2022

Aug 12, 2022

BUY
$3.01 - $4.46 $312,438 - $462,948
103,800 Added 151.31%
172,400 $548,000
Q1 2022

May 13, 2022

BUY
$3.9 - $4.89 $267,540 - $335,454
68,600 New
68,600 $286,000
Q2 2021

Aug 13, 2021

SELL
$5.12 - $6.82 $2.3 Million - $3.06 Million
-448,660 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$4.74 - $7.38 $1.31 Million - $2.04 Million
276,111 Added 160.02%
448,660 $3.02 Million
Q4 2020

Feb 10, 2021

BUY
$3.95 - $5.42 $681,568 - $935,215
172,549 New
172,549 $789,000
Q3 2019

Nov 13, 2019

SELL
$2.29 - $7.1 $164,193 - $509,070
-71,700 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$6.44 - $14.29 $2.03 Million - $4.51 Million
-315,700 Reduced 81.49%
71,700 $514,000
Q1 2019

May 14, 2019

SELL
$11.87 - $14.84 $6.72 Million - $8.4 Million
-566,300 Reduced 59.38%
387,400 $5.49 Million
Q4 2018

Feb 13, 2019

BUY
$13.09 - $21.49 $12.5 Million - $20.5 Million
953,700 New
953,700 $12.9 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $961M
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.